FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
Kawaguchi
T
T
Research Laboratories of Yoshitomi Pharmaceutical Industries, Ltd., Saitama, Japan.
Hoshino
Y
Y
Rahman
F
F
Amano
Y
Y
Higashi
H
H
Kataoka
H
H
Ohtsuki
M
M
Teshima
K
K
Chiba
K
K
Kakefuda
T
T
Suzuki
S
S
D000818:Animals; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004285:Dogs; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016572:Cyclosporine; D003404:Creatinine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine